Early-stage research platform Morressier integrates ORCID iDs to connect research from start to end

BERLIN - March 22, 2019 - PRLog -- Morressier, the world's largest platform for early-stage research, today announced an integration with ORCID. This provides researchers with a unique way to organize, structure, and legitimize their pre-published research and marks an important step towards connecting the entire research lifecycle from beginning to end.

Sami Benchekroun, Morressier CEO, said: "At Morressier, we are committed to making early-stage research open and discoverable to provide the most complete picture of an author's work. We are thrilled to partner with ORCID on this mission, an organization whose goals of making research more transparent, trustworthy, and connected strongly align with ours."

Laurel Haak, Executive Director of ORCID, said: "We are excited that researchers will now be able to share and get recognition for their conference posters, presentations, and abstracts as a result of Morressier's ORCID integration."

All current and new Morressier members will now be able to log into the platform using their ORCID iDs and have their conference data added to their ORCID records. By using a unique and persistent identifier, authors will be able to highlight the full scope of their work, including their pre-published research. This also means that published articles can be traced back to the first findings that are openly presented at conferences, helping to structure and connect the dots in the research process.

The integration of ORCID identifiers on Morressier is especially important for early-career researchers. For the first time, they can use their pre-published research to help position themselves professionally and build their reputation before they have a comprehensive set of journal articles under their belt. As a next step, Morressier will focus on further growing its platform of early-stage research and on integrating more tools and services that researchers need to make progress in their work.


About Morressier

Founded in 2014, Morressier (https://morressier.com/) is the home for early-stage research. By making previously hidden findings discoverable from the very beginning of the research lifecycle, Morressier aims to accelerate scientific breakthroughs. Pre-published research is disseminated on the Morressier platform, helping to increase its reach and providing the entire scientific ecosystem with trends, analytics and signals in science as they happen. Based in Berlin, the company is backed by funding from Cherry Ventures, Redalpine, and industry expert angel investors, including Jan Reichelt (Mendeley & Kopernio), Annette Thomas (Clarivate Analytics), Jan Maier (AVEDAS), and Thomas Jørgensen (Atira).

About ORCID

ORCID (https://orcid.org/) is an international non-profit organization working to create a world in which all who participate in research and innovation are uniquely identified and connected to their contributions and affiliations across disciplines, borders, and time. ORCID provides an identifier for individuals to use with their name as they engage in research and innovation activities. ORCID provides open tools that enable transparent and trustworthy connections. These services help people find information and simplify reporting and analysis.